Table 4.
Association of average pedometer steps/day with metabolic syndrome and its components.
| Pittsburgh (n = 265) |
Kusatsu (n = 245) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Model 1 |
Model 2 |
Model 1 |
Model 2 |
|||||
| β | OR (95%CI) | β | OR (95%CI) | β | OR (95%CI) | β | OR (95%CI) | |
| Metabolic syndrome a | –0.108 | 0.90 (0.83–0.98)* | –0.106 | 0.90 (0.83–0.98)* | –0.1421 | 0.87 (0.79–0.95)* | –0.139 | 0.87 (0.80–0.95)* |
| High waist circumference b | –0.150 | 0.86 (0.79–0.94)* | –0.148 | 0.86 (0.79–0.94)* | –0.1332 | 0.88 (0.80–0.95)* | –0.139 | 0.87 (0.80–0.95)* |
| High triglycerides c | –0.074 | 0.93 (0.86–1.01) | –0.077 | 0.93 (0.86–1.00) | –0.0778 | 0.93 (0.86–0.99)* | –0.078 | 0.93 (0.86–0.99)* |
| High blood pressured | –0.038 | 0.96 (0.89–1.04) | –0.042 | 0.96 (0.90–1.03) | –0.0543 | 0.95 (0.88–1.01) | –0.060 | 0.94 (0.88–1.01) |
| High blood glucose e | –0.036 | 0.97 (0.89–1.04) | –0.033 | 0.97 (0.89–1.05) | –0.0312 | 0.97 (0.91–1.04) | –0.030 | 0.97 (0.91–1.04) |
| Low HDL cholesterol f | –0.003 | 1.00 (0.92–1.09) | –0.006 | 0.99 (0.91–1.08) | –0.0936 | 0.91 (0.80–1.04) | –0.067 | 0.94 (0.82–1.07) |
| Obesity g | –0.123 | 0.89 (0.81–0.97)* | –0.121 | 0.89 (0.81–0.97)* | –0.0642 | 0.94 (0.87–1.01) | –0.071 | 0.93 (0.86–1.01) |
Note: Betas and ORs are expressed per 1000 pedometer steps/day. Model 1: unadjusted; Model 2: Model 1 + age, smoking, and alcohol.
a ≥3 of 5 components; b ≥102 cm in American men and ≥90 cm in Japanese men; c Systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or on medication; d Triglycerides ≥150 mg/dL or on medication; e HDL-cholesterol <40 mg/dL or on medication; f Fasting glucose ≥100 mg/dL or on medication; g BMI ≥30 kg/m2 in American men and BMI ≥25 kg/m2 in Japanese men.
* p < 0.05.
Abbreviations: BMI = body mass index; CI = confidential interval; HDL = high density lipoprotein; LDL = low density lipoprotein; OR = odds ratio.